Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial.
Zhihao LuJunye WangYongqian ShuLianke LiuLi KongLei YangBuhai WangGuogui SunYinghua JiGuochun CaoHu LiuTongjian CuiNa LiWensheng QiuGaofeng LiXinfang HouHui LuoLiying XueYanqiao ZhangWenbin YueZheng LiuXiuwen WangShegan GaoYueyin PanMarie-Pierre GalaisAziz ZaananZhuo MaHaoyu LiYan WangLin Shennull nullPublished in: BMJ (Clinical research ed.) (2022)
ClinicalTrials.gov NCT03748134.